Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1WQR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $61,807
Award facts
- Contract value 100% obligated
- $61,806.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $61,806.62 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml syringes on January 5, 2026, with an ultimate completion date of January 6, 2026. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and extends through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through the DLA's Medical Supply Chain. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. This delivery order for Dupixent, a specialty pharmaceutical treatment, exemplifies the company's role in fulfilling federal medical procurement requirements across multiple therapeutic domains through open competition.
Quick answers
Who was awarded contract SPE2DR26F1WQR?
SPE2DR26F1WQR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26F1WQR worth?
The government has obligated $61,807 on SPE2DR26F1WQR.
Is contract SPE2DR26F1WQR an order under another contract?
Yes. SPE2DR26F1WQR is a delivery order under SPE2DR25D3402, an indefinite delivery contract.
Was contract SPE2DR26F1WQR competed?
The extent of competition for SPE2DR26F1WQR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award